Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Monath

Showing results (41-50 of 136) with videos related to

Pageof 14
Sort By:
Viruses|December 20, 2013
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virusGustavo H Dayan, Konstantin Pugachev, Joan Bevilacqua, et al.
Human Vaccines & Immunotherapeutics|December 6, 2017
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector speciesNicholas A Bergren, Megan R Miller, Thomas P Monath, et al.
Emerging Infectious Diseases|May 24, 2006
Lack of transmission of vaccinia virusJames H Stark, Sharon E Frey, Paul S Blum, et al.
Vaccine|October 8, 2009
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesBruno Guy, Farshad Guirakhoo, Veronique Barban, et al.
Vaccine|January 23, 2002
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencingKonstantin V Pugachev, Simeon W Ocran, Farshad Guirakhoo, et al.
Vaccine|March 21, 2007
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005Alan D T Barrett, Thomas P Monath, Veronique Barban, et al.
Vaccine|December 14, 2007
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challengeKathleen A Marriott, Christopher V Parkinson, Samantha I Morefield, et al.
Journal of Travel Medicine|April 2, 2009
Yellow fever recommendations for tourists to Kenya: a flawed risk assessmentThomas P Monath, Mark Gershman, David R Hill, et al.
Journal of Virology|January 19, 2002
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccinesThomas P Monath, Juan Arroyo, Inessa Levenbook, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virusKathryn A Hanley, Thomas P Monath, Scott C Weaver, et al.
Pageof 14

Showing results (41-50 of 136) with videos related to

Sort By:
Pageof 14
Viruses|December 20, 2013
Preclinical and clinical development of a YFV 17 D-based chimeric vaccine against West Nile virusGustavo H Dayan, Konstantin Pugachev, Joan Bevilacqua, et al.
Human Vaccines & Immunotherapeutics|December 6, 2017
Assessment of the ability of V920 recombinant vesicular stomatitis-Zaire ebolavirus vaccine to replicate in relevant arthropod cell cultures and vector speciesNicholas A Bergren, Megan R Miller, Thomas P Monath, et al.
Emerging Infectious Diseases|May 24, 2006
Lack of transmission of vaccinia virusJames H Stark, Sharon E Frey, Paul S Blum, et al.
Vaccine|October 8, 2009
Preclinical and clinical development of YFV 17D-based chimeric vaccines against dengue, West Nile and Japanese encephalitis virusesBruno Guy, Farshad Guirakhoo, Veronique Barban, et al.
Vaccine|January 23, 2002
Heterogeneous nature of the genome of the ARILVAX yellow fever 17D vaccine revealed by consensus sequencingKonstantin V Pugachev, Simeon W Ocran, Farshad Guirakhoo, et al.
Vaccine|March 21, 2007
17D yellow fever vaccines: new insights. A report of a workshop held during the World Congress on medicine and health in the tropics, Marseille, France, Monday 12 September 2005Alan D T Barrett, Thomas P Monath, Veronique Barban, et al.
Vaccine|December 14, 2007
Clonal vaccinia virus grown in cell culture fully protects monkeys from lethal monkeypox challengeKathleen A Marriott, Christopher V Parkinson, Samantha I Morefield, et al.
Journal of Travel Medicine|April 2, 2009
Yellow fever recommendations for tourists to Kenya: a flawed risk assessmentThomas P Monath, Mark Gershman, David R Hill, et al.
Journal of Virology|January 19, 2002
Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: relevance to development and safety testing of live, attenuated vaccinesThomas P Monath, Juan Arroyo, Inessa Levenbook, et al.
Infection, Genetics and Evolution : Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases|March 26, 2013
Fever versus fever: the role of host and vector susceptibility and interspecific competition in shaping the current and future distributions of the sylvatic cycles of dengue virus and yellow fever virusKathryn A Hanley, Thomas P Monath, Scott C Weaver, et al.
Pageof 14